Hepatitis questions on Step 1 are rarely about memorizing random viral trivia—they’re about recognizing patterns: hepatocellular vs cholestatic injury, acute vs chronic timelines, and the classic serology/complication associations that show up in stems. If you can quickly sort “transaminitis + symptoms” into the right bucket and attach the right virus + risk factors + serology, you’ll pick up a lot of easy points.
Big Picture: What “Hepatitis” Means (and Why It Matters)
Hepatitis = inflammation and injury of hepatocytes, most commonly due to viruses (A–E), alcohol, drugs/toxins (e.g., acetaminophen), ischemia, autoimmune disease, and metabolic disorders.
Acute vs Chronic (Step 1 definition)
| Feature | Acute hepatitis | Chronic hepatitis |
|---|---|---|
| Time course | < 6 months | > 6 months |
| Typical causes | HAV, HEV, acute HBV, drugs/toxins, ischemic hepatitis | HBV, HCV, autoimmune hepatitis, metabolic (NAFLD/NASH), drugs |
| Key risk | Acute liver failure (rare; depends on cause) | Cirrhosis, portal HTN, hepatocellular carcinoma (HCC) |
High-yield rule: HBV and HCV are the big chronic players (HEV can be severe in pregnancy but classically not chronic; note rare chronic HEV in immunocompromised—less Step 1-relevant).
Pathophysiology: What’s Actually Happening in the Liver
The core mechanism (especially viral hepatitis)
Much of the liver injury in viral hepatitis is immune-mediated:
- Hepatocytes infected with virus present antigen on MHC I
- CD8+ cytotoxic T cells attack infected hepatocytes
This helps explain why the immune response both: - clears infection (good), and
- causes hepatocyte damage (bad)
Acute hepatitis: histology you should recognize
- Ballooning degeneration (swollen hepatocytes)
- Councilman bodies = apoptotic hepatocytes (classically seen in acute viral hepatitis)
Chronic hepatitis: fibrosis pattern you should know
- Persistent inflammation → piecemeal necrosis and progressive fibrosis
- Bridging fibrosis + regenerative nodules → cirrhosis
- Cirrhosis drives: portal HTN, ascites, varices, encephalopathy, HCC risk
Clinical Presentation: Symptoms + Timing = Your Diagnosis Shortcut
Common acute viral hepatitis presentation
Often a prodrome followed by jaundice:
- Malaise, fatigue, anorexia
- Nausea/vomiting
- RUQ pain
- Low-grade fever
- Then: jaundice, dark urine, pale stools, pruritus (more cholestatic)
Exam tip: Many patients—especially children—can be asymptomatic (important for transmission and “incidental elevated AST/ALT” questions).
Chronic hepatitis presentation
Often subtle until advanced:
- Fatigue, malaise
- Mild RUQ discomfort
- Signs of chronic liver disease later: spider angiomas, palmar erythema, gynecomastia, splenomegaly, ascites
Labs & Patterns: Hepatocellular vs Cholestatic Injury
Step 1 pattern recognition table
| Pattern | Key labs | Think |
|---|---|---|
| Hepatocellular injury | AST/ALT very high (often > 1000 in severe cases) | Viral hepatitis, ischemic hepatitis, toxins (acetaminophen) |
| Cholestatic injury | ALP high, direct bilirubin high, pruritus | Biliary obstruction, PBC/PSC, drug cholestasis |
| Synthetic dysfunction | ↑ PT/INR, ↓ albumin | Severe acute liver failure or advanced chronic disease |
High-yield: In acute liver failure, PT/INR rises early (short half-life of clotting factors). That’s why INR is a key severity marker.
Viral Hepatitis Deep Dive (A–E): Transmission, Chronicity, and High-Yield Clues
Quick high-yield comparison
| Virus | Transmission | Incubation vibe | Chronic? | High-yield associations |
|---|---|---|---|---|
| HAV | Fecal-oral (food/water), daycare | Shorter | No | Outbreaks, travel; supportive care; vaccine |
| HBV | Blood, sex, perinatal | Medium | Yes | Polyarteritis nodosa, membranous nephropathy; HCC risk |
| HCV | Blood (IVDU), transfusion (old), needles | Often silent | Yes (most) | Mixed cryoglobulinemia, MPGN; highest chronicity |
| HDV | Needs HBV (HBsAg) | — | Can worsen | Co-infection vs superinfection |
| HEV | Fecal-oral (water) | Similar to HAV | Usually no | Severe in pregnancy (fulminant) |
Hepatitis A (HAV): The “Acute, Self-Limited” Classic
Key points
- Transmission: fecal-oral (contaminated food/water), close contact
- Course: acute, self-limited; does not become chronic
- Diagnosis: anti-HAV IgM = acute infection; anti-HAV IgG = immunity (past infection or vaccination)
- Treatment: supportive
- Prevention: inactivated vaccine; immune globulin for post-exposure in certain settings
First Aid cross-ref: Microbiology → Hepatitis viruses (HAV: picornavirus, +ssRNA; fecal-oral; no chronic infection)
Hepatitis B (HBV): The Serology Goldmine
Key points
- Transmission: blood, sexual contact, perinatal
- Virus: partially dsDNA hepadnavirus; uses reverse transcriptase
- Chronicity: depends on age:
- adults: lower chronic risk
- neonates/perinatal: high chronic risk
High-yield extrahepatic associations
- Polyarteritis nodosa (PAN) (medium-vessel vasculitis)
- Membranous nephropathy (and can also be associated with MPGN)
HBV serology (the Step 1 must-know)
| Marker | What it means |
|---|---|
| HBsAg | Current infection (acute or chronic) |
| Anti-HBs | Immunity (recovered or vaccinated) |
| Anti-HBc IgM | Acute infection (recent) |
| Anti-HBc IgG | Past exposure or chronic infection (not from vaccine) |
| HBeAg | High viral replication, high infectivity |
| Anti-HBe | Lower infectivity |
| HBV DNA | Viral load; replication; used to monitor therapy |
The “window period” (classic trap)
- HBsAg is gone, anti-HBs not yet formed
- Only reliable positive marker: anti-HBc IgM
Treatment (Step 1 framing)
- Acute HBV: often supportive (unless severe/fulminant)
- Chronic HBV: antivirals such as tenofovir, entecavir (and sometimes peg-IFN)
- Prevention: vaccine (HBsAg) + HBIG for post-exposure/perinatal prophylaxis
First Aid cross-ref: Micro → HBV serology tables; Pharm → antivirals (tenofovir/entecavir); Path → complications (HCC, PAN)
Hepatitis C (HCV): High Chronicity + Mixed Cryoglobulinemia
Key points
- Transmission: blood (especially IVDU), needlestick
- Virus: +ssRNA flavivirus
- Course: often asymptomatic acute infection → high rate of chronic infection
- Complications: cirrhosis and HCC; extrahepatic syndromes
High-yield extrahepatic associations
- Mixed cryoglobulinemia (can cause palpable purpura, arthralgias, weakness)
- Membranoproliferative glomerulonephritis (MPGN)
- Can be linked with porphyria cutanea tarda and lichen planus (more Step 2-ish but fair game)
Diagnosis
- Screen: anti-HCV antibodies
- Confirm/monitor: HCV RNA (viral load)
Treatment
- Direct-acting antivirals (DAAs) with high cure rates (drug combos vary; Step 1 doesn’t usually test specific regimens)
First Aid cross-ref: Micro → HCV chronicity; Path → MPGN/cryoglobulinemia; Pharm → antivirals overview
Hepatitis D (HDV): Needs HBV to Exist
Key points
- Defective -ssRNA virus that requires HBsAg to assemble
- Occurs as:
- Coinfection (HBV + HDV together): tends to be less likely chronic than superinfection
- Superinfection (HDV infects someone with chronic HBV): more severe, higher risk of fulminant hepatitis and chronic disease
High-yield stem clue: Known HBV patient gets sudden worsening hepatitis → think HDV superinfection.
First Aid cross-ref: Micro → HDV requires HBsAg; clinical severity differences
Hepatitis E (HEV): Think “Pregnancy + Fulminant”
Key points
- Transmission: fecal-oral (waterborne outbreaks), common in developing regions
- Course: usually acute, self-limited
- High-yield association: pregnant patients → increased risk of fulminant hepatitis and mortality
First Aid cross-ref: Micro → HEV severe in pregnancy
Acute Hepatitis: Diagnosis & Severity (What Step 1 Likes)
Diagnostic approach (conceptual)
- Recognize hepatocellular injury: AST/ALT elevated
- Assess severity: PT/INR, mental status (encephalopathy), bilirubin
- Identify cause:
- Viral serologies (HAV IgM, HBV panel, HCV Ab/RNA)
- Medication/toxin history (acetaminophen)
- Ischemia (shock liver—very high AST/ALT)
Fulminant hepatic failure (high-yield)
Acute liver failure = encephalopathy + impaired synthetic function (↑ INR) in a patient without preexisting cirrhosis.
Common causes to remember:
- Acetaminophen toxicity
- Acute viral hepatitis (HBV, rarely HAV/HEV)
- Ischemic hepatitis
Chronic Hepatitis: Complications You Must Be Ready to Spot
Major long-term outcomes
- Cirrhosis → portal HTN, ascites, varices, splenomegaly, thrombocytopenia
- Hepatocellular carcinoma (HCC) risk increases with:
- chronic HBV (can occur even without cirrhosis)
- chronic HCV (usually via cirrhosis)
- aflatoxin exposure (Step 1 classic tie-in)
HCC “big picture” screening concept (Step-level)
- Chronic viral hepatitis → surveillance (often ultrasound ± AFP; mostly Step 2/clinical, but the association itself is Step 1 high yield)
High-Yield “Acute vs Chronic” Differentiators in Vignettes
Acute viral hepatitis clue cluster
- Recent exposure (travel, daycare outbreak, IVDU/needlestick, sexual contact)
- Systemic symptoms + jaundice
- Marked transaminitis
- Positive IgM markers (HAV IgM, HBc IgM)
Chronic hepatitis clue cluster
- Mild symptoms or incidental labs
- Stigmata of chronic liver disease
- Evidence of portal HTN
- Viral loads/antibodies consistent with chronicity (HBsAg > 6 months, anti-HBc IgG; HCV RNA persistence)
Rapid-Fire USMLE High-Yield Pearls (Memorize These)
- Acute vs chronic cutoff: 6 months
- Window period marker: anti-HBc IgM
- Vaccination for HBV: produces anti-HBs (no anti-HBc)
- HCV: highest chronicity + mixed cryoglobulinemia + MPGN
- HBV: associated with PAN and membranous nephropathy
- HDV: requires HBsAg; superinfection worse than coinfection
- HEV: danger in pregnancy (fulminant)
- Councilman bodies: apoptotic hepatocytes in acute viral hepatitis
- In acute liver failure, INR rises early (best severity/synthetic function marker)
First Aid Cross-Reference Map (Quick Study Guide)
Use this as a “where to flip” checklist while you annotate:
- Microbiology (Hepatitis viruses): transmission routes, chronicity, HDV dependence on HBV, HEV pregnancy severity
- Pathology (Liver): acute vs chronic hepatitis histology, cirrhosis complications, HCC associations
- Immunology: CD8+ T-cell mediated hepatocyte injury (MHC I)
- Pharmacology: HBV antivirals (e.g., tenofovir, entecavir), interferon concepts; acetaminophen toxicity (differential for massive AST/ALT)